Current Status and Research Strategies in Tuberculosis Drug Development

Lynn Dover; Geoffrey Coxon

doi:10.1021/jm200305q

Current Status and Research Strategies in Tuberculosis Drug Development

Lynn Dover, Geoffrey Coxon

Research output: Contribution to journal › Article › peer-review

117 Citations (Scopus)

Original language	English
Pages (from-to)	6157-6165
Journal	Journal of Medicinal Chemistry
Volume	54
Issue number	18
DOIs	https://doi.org/10.1021/jm200305q
Publication status	Published - 2011

Keywords

Mycobacterium
tuberculosis
drugs
development

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1021/jm200305q

Cite this

@article{1a2115403c8d44e18c0df99acf644925,

title = "Current Status and Research Strategies in Tuberculosis Drug Development",

keywords = "Mycobacterium, tuberculosis, drugs, development",

author = "Lynn Dover and Geoffrey Coxon",

year = "2011",

doi = "10.1021/jm200305q",

language = "English",

volume = "54",

pages = "6157--6165",

journal = "Journal of Medicinal Chemistry",

issn = "0022-2623",

publisher = "American Chemical Society",

number = "18",

}

TY - JOUR

T1 - Current Status and Research Strategies in Tuberculosis Drug Development

AU - Dover, Lynn

AU - Coxon, Geoffrey

PY - 2011

Y1 - 2011

KW - Mycobacterium

KW - tuberculosis

KW - drugs

KW - development

UR - https://www.scopus.com/pages/publications/80052814263

U2 - 10.1021/jm200305q

DO - 10.1021/jm200305q

M3 - Article

SN - 0022-2623

VL - 54

SP - 6157

EP - 6165

JO - Journal of Medicinal Chemistry

JF - Journal of Medicinal Chemistry

IS - 18

ER -

Current Status and Research Strategies in Tuberculosis Drug Development

Keywords

UN SDGs

Access to Document

Other files and links

Cite this